Search Results - "van Nieuwland, Marieke"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic by van Nieuwland, Marieke, van Bon, Lenny, Vermeer, Marloes, Brouwer, Elisabeth, Alves, Celina

    Published in Rheumatic & musculoskeletal diseases open (01-07-2023)
    “…ObjectiveRecently the Diagnostic and Classification Criteria in Vasculitis Study group developed and published new American College of Rheumatology/EULAR…”
    Get full text
    Journal Article
  2. 2

    Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients by van Nieuwland, Marieke, Esen, Idil, Reitsema, Rosanne D, Abdulahad, Wayel H, van Sleen, Yannick, Jiemy, William F, Sandovici, Maria, Brouwer, Elisabeth, van Bon, Lenny

    Published in Frontiers in immunology (2023)
    “…Giant cell arteritis (GCA) is a vasculitis of the medium- and large-sized arteries. Interferon type I (IFN-I) is increasingly recognized as a key player in…”
    Get full text
    Journal Article
  3. 3

    Comparing Diagnostic Performance of Short and Long [ 18 F]FDG-PET Acquisition Times in Giant Cell Arteritis by Nienhuis, Pieter H, van Nieuwland, Marieke, van Praagh, Gijs D, Markusiewicz, Karolina, Colin, Edgar M, van der Geest, Kornelis S M, Wagenaar, Nils, Brouwer, Elisabeth, Alves, Celina, Slart, Riemer H J A

    Published in Diagnostics (Basel) (01-01-2024)
    “…(1) Background: In giant cell arteritis (GCA), the assessment of cranial arteries using [ F]fluorodeoxyglucose ([ F]FDG) positron emission tomography (PET)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Diagnostic delay in patients with giant cell arteritis: results of a fast-track clinic by van Nieuwland, Marieke, Colin, Edgar M., Boumans, Dennis, Vermeer, Marloes, Brouwer, Elisabeth, Alves, Celina

    Published in Clinical rheumatology (2024)
    “…Giant cell arteritis (GCA) can lead to severe complications if left untreated. The aim of this study was to describe time from onset of symptoms to diagnosis…”
    Get full text
    Journal Article
  6. 6

    Investigating Interferon type I responses in patients with suspected giant cell arteritis and polymyalgia rheumatica by van Nieuwland, Marieke, Mulder, A H Leontine, Colin, Edgar M, Alves, Celina, van Bon, Lenny, Brouwer, Elisabeth

    Published in Clinical and experimental immunology (12-11-2024)
    “…Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related inflammatory disorders. Easily measurable biomarkers defining active disease…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Culture Conditions Affect Chemical-Induced Developmental Toxicity In Vitro: The Case of Folic Acid, Methionine and Methotrexate in the Neural Embryonic Stem Cell Test by de Leeuw, Victoria C., van Nieuwland, Marieke, Bokkers, Bas G.H., Piersma, Aldert H.

    Published in Alternatives to laboratory animals (01-07-2020)
    “…In vitro tests are increasingly applied in chemical hazard assessment. Basic culture conditions may affect the outcome of in vitro tests and should be…”
    Get full text
    Journal Article
  10. 10

    Comparing Diagnostic Performance of Short and Long 18FFDG-PET Acquisition Times in Giant Cell Arteritis by Nienhuis, Pieter H, van Nieuwland, Marieke, van Praagh, Gijs D, Markusiewicz, Karolina, Colin, Edgar M, van der Geest, Kornelis S M, Wagenaar, Nils, Brouwer, Elisabeth, Alves, Celina, Slart, Riemer H J A

    Published in Diagnostics (Basel) (27-12-2023)
    “…(1) Background: In giant cell arteritis (GCA), the assessment of cranial arteries using [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET)…”
    Get full text
    Journal Article